Cargando…

Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report

Patient: Female, 67-year-old Final Diagnosis: Rhabdomyolysis Symptoms: Weakness Medication:— Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: Rhabdomyolysis occurs when muscle injury leads to the release of muscle cell constituents...

Descripción completa

Detalles Bibliográficos
Autores principales: Byler, Julie, Harrison, Rebecca, Fell, Lindsey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127859/
https://www.ncbi.nlm.nih.gov/pubmed/33963170
http://dx.doi.org/10.12659/AJCR.931616
_version_ 1783694028841156608
author Byler, Julie
Harrison, Rebecca
Fell, Lindsey L.
author_facet Byler, Julie
Harrison, Rebecca
Fell, Lindsey L.
author_sort Byler, Julie
collection PubMed
description Patient: Female, 67-year-old Final Diagnosis: Rhabdomyolysis Symptoms: Weakness Medication:— Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: Rhabdomyolysis occurs when muscle injury leads to the release of muscle cell constituents into circulation, often leading to significant systemic complications. There are many causes of rhabdomyolysis, and the etiology is often multifactorial or unclear. Current data suggest that acute COVID-19 may cause muscle injury that can lead to rhabdomyolysis, particularly in cases of severe illness requiring prolonged hospitalization; however, data on the long-term effects of COVID-19 on the musculoskeletal system are lacking. CASE REPORT: We present a case of a woman with generalized weakness 1 week following discharge from the hospital after a prolonged admission for severe COVID-19. She was found to have acute kidney injury and elevated creatine kinase (CK) of 1775 U/L (normal 36-234 U/L). Her home medications, including her statin, were held, but her CK continued to rise, peaking at 15 085 U/L, and she developed renal failure necessitating renal replacement therapy. A thorough work-up for the underlying etiology of her rhabdomyolysis was pursued, including testing for autoimmune myositis, statin-associated necrotizing autoimmune myositis, and a muscle biopsy, which were all unrevealing. Ultimately, the patient’s rhabdomyolysis was determined to likely be secondary to a post-viral myopathy from COVID-19. A toxic myopathy from medication use or a delayed critical illness myopathy from her recent prolonged hospitalization could have also contributed. CONCLUSIONS: This case highlights the wide differential diagnosis of rhabdomyolysis in the setting of recent COVID-19 and prolonged hospitalization. It demonstrates the possibility that muscle injury and resultant rhabdomyolysis may be a late complication of COVID-19 that is not yet fully described in the literature.
format Online
Article
Text
id pubmed-8127859
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-81278592021-05-24 Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report Byler, Julie Harrison, Rebecca Fell, Lindsey L. Am J Case Rep Articles Patient: Female, 67-year-old Final Diagnosis: Rhabdomyolysis Symptoms: Weakness Medication:— Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: Rhabdomyolysis occurs when muscle injury leads to the release of muscle cell constituents into circulation, often leading to significant systemic complications. There are many causes of rhabdomyolysis, and the etiology is often multifactorial or unclear. Current data suggest that acute COVID-19 may cause muscle injury that can lead to rhabdomyolysis, particularly in cases of severe illness requiring prolonged hospitalization; however, data on the long-term effects of COVID-19 on the musculoskeletal system are lacking. CASE REPORT: We present a case of a woman with generalized weakness 1 week following discharge from the hospital after a prolonged admission for severe COVID-19. She was found to have acute kidney injury and elevated creatine kinase (CK) of 1775 U/L (normal 36-234 U/L). Her home medications, including her statin, were held, but her CK continued to rise, peaking at 15 085 U/L, and she developed renal failure necessitating renal replacement therapy. A thorough work-up for the underlying etiology of her rhabdomyolysis was pursued, including testing for autoimmune myositis, statin-associated necrotizing autoimmune myositis, and a muscle biopsy, which were all unrevealing. Ultimately, the patient’s rhabdomyolysis was determined to likely be secondary to a post-viral myopathy from COVID-19. A toxic myopathy from medication use or a delayed critical illness myopathy from her recent prolonged hospitalization could have also contributed. CONCLUSIONS: This case highlights the wide differential diagnosis of rhabdomyolysis in the setting of recent COVID-19 and prolonged hospitalization. It demonstrates the possibility that muscle injury and resultant rhabdomyolysis may be a late complication of COVID-19 that is not yet fully described in the literature. International Scientific Literature, Inc. 2021-05-08 /pmc/articles/PMC8127859/ /pubmed/33963170 http://dx.doi.org/10.12659/AJCR.931616 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Byler, Julie
Harrison, Rebecca
Fell, Lindsey L.
Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title_full Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title_fullStr Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title_full_unstemmed Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title_short Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report
title_sort rhabdomyolysis following recovery from severe covid-19: a case report
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127859/
https://www.ncbi.nlm.nih.gov/pubmed/33963170
http://dx.doi.org/10.12659/AJCR.931616
work_keys_str_mv AT bylerjulie rhabdomyolysisfollowingrecoveryfromseverecovid19acasereport
AT harrisonrebecca rhabdomyolysisfollowingrecoveryfromseverecovid19acasereport
AT felllindseyl rhabdomyolysisfollowingrecoveryfromseverecovid19acasereport